Brown, Christine E. http://orcid.org/0000-0003-4915-8207
Hibbard, Jonathan C.
Alizadeh, Darya
Blanchard, M. Suzette
Natri, Heini M.
Wang, Dongrui
Ostberg, Julie R.
Aguilar, Brenda
Wagner, Jamie R.
Paul, Jinny A.
Starr, Renate
Wong, Robyn A.
Chen, Wuyang
Shulkin, Noah
Aftabizadeh, Maryam
Filippov, Aleksandr http://orcid.org/0000-0001-8084-661X
Chaudhry, Ammar
Ressler, Julie A.
Kilpatrick, Julie
Myers-McNamara, Paige
Chen, Mike
Wang, Leo D.
Rockne, Russell C. http://orcid.org/0000-0002-1557-159X
Georges, Joseph
Portnow, Jana
Barish, Michael E.
D’Apuzzo, Massimo http://orcid.org/0000-0001-8146-0997
Banovich, Nicholas E.
Forman, Stephen J. http://orcid.org/0000-0002-2803-4152
Badie, Behnam
Funding for this research was provided by:
California Institute for Regenerative Medicine (CLIN2-12153)
Gateway for Cancer Research (G-14-600)
U.S. Department of Health & Human Services | U.S. Food and Drug Administration (R01FD005129)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (K12CA001727, R01CA155769)
Article History
Received: 27 June 2023
Accepted: 15 February 2024
First Online: 7 March 2024
Change Date: 21 March 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41591-024-02928-5
Competing interests
: C.E.B. and S.J.F. report personal fees, patent royalties and research support from Mustang Bio during the conduct of the study, as well as patent royalties from Chimeric Therapeutics outside the submitted work. C.E.B., S.J.F. and B.B. also have a patent for CAR-T cell delivery pending and with royalties payable from Mustang Bio. N.E.B. receives compensation from DeepCell. The other authors declare no competing interests.